Selected research
Industry Research
Cycloheximide Industry Research Report 2026
Market perspective
The global Cycloheximide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cycloheximide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cycloheximide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cycloheximide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cycloheximide include 3B Scientific, Hopebio, Yunbang Bioscience, Sigma-Aldrich, Glentham Life Science, Broad Pharm, Biotechne, Biosynth and AK Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cycloheximide market in terms of revenue (US$ million) and, where applicable, sales volume (g), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/g) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cycloheximide Market by Company
3B Scientific
Hopebio
Yunbang Bioscience
Sigma-Aldrich
Glentham Life Science
Broad Pharm
Biotechne
Biosynth
AK Scientific
AHH Chemical
Cycloheximide Segment by Type
97% Purity Type
95% Purity Type
94% Purity Type
Others
Cycloheximide Segment by Application
Microbial Culture Additive
Agricultural Additive
Others
Cycloheximide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cycloheximide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cycloheximide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cycloheximide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cycloheximide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cycloheximide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cycloheximide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 97% Purity Type
- 95% Purity Type
- 94% Purity Type
- Others
Applications
- Microbial Culture Additive
- Agricultural Additive
- Others
Companies covered
- 3B Scientific
- Hopebio
- Yunbang Bioscience
- Sigma-Aldrich
- Glentham Life Science
- Broad Pharm
- Biotechne
- Biosynth
- AK Scientific
- AHH Chemical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cycloheximide Market Size (2021-2032)
- 2.2.2 Global Cycloheximide Sales (2021-2032)
- 2.2.3 Global Cycloheximide Market Average Price (2021-2032)
- 2.3 Cycloheximide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 97% Purity Type
- 2.3.3 95% Purity Type
- 2.3.4 94% Purity Type
- 2.3.5 Others
- 2.4 Cycloheximide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Microbial Culture Additive
- 2.4.3 Agricultural Additive
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cycloheximide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cycloheximide Sales (g) of Manufacturers (2021-2026)
- 3.3 Global Cycloheximide Revenue of Manufacturers (2021-2026)
- 3.4 Global Cycloheximide Average Price by Manufacturers (2021-2026)
- 3.5 Global Cycloheximide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cycloheximide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cycloheximide, Product Type & Application
- 3.8 Global Manufacturers of Cycloheximide, Established Date
- 3.9 Global Cycloheximide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 3B Scientific
- 4.1.1 3B Scientific Company Information
- 4.1.2 3B Scientific Business Overview
- 4.1.3 3B Scientific Cycloheximide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 3B Scientific Cycloheximide Product Portfolio
- 4.1.5 3B Scientific Recent Developments
- 4.2 Hopebio
- 4.2.1 Hopebio Company Information
- 4.2.2 Hopebio Business Overview
- 4.2.3 Hopebio Cycloheximide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hopebio Cycloheximide Product Portfolio
- 4.2.5 Hopebio Recent Developments
- 4.3 Yunbang Bioscience
- 4.3.1 Yunbang Bioscience Company Information
- 4.3.2 Yunbang Bioscience Business Overview
- 4.3.3 Yunbang Bioscience Cycloheximide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Yunbang Bioscience Cycloheximide Product Portfolio
- 4.3.5 Yunbang Bioscience Recent Developments
- 4.4 Sigma-Aldrich
- 4.4.1 Sigma-Aldrich Company Information
- 4.4.2 Sigma-Aldrich Business Overview
- 4.4.3 Sigma-Aldrich Cycloheximide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sigma-Aldrich Cycloheximide Product Portfolio
- 4.4.5 Sigma-Aldrich Recent Developments
- 4.5 Glentham Life Science
- 4.5.1 Glentham Life Science Company Information
- 4.5.2 Glentham Life Science Business Overview
- 4.5.3 Glentham Life Science Cycloheximide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Glentham Life Science Cycloheximide Product Portfolio
- 4.5.5 Glentham Life Science Recent Developments
- 4.6 Broad Pharm
- 4.6.1 Broad Pharm Company Information
- 4.6.2 Broad Pharm Business Overview
- 4.6.3 Broad Pharm Cycloheximide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Broad Pharm Cycloheximide Product Portfolio
- 4.6.5 Broad Pharm Recent Developments
- 4.7 Biotechne
- 4.7.1 Biotechne Company Information
- 4.7.2 Biotechne Business Overview
- 4.7.3 Biotechne Cycloheximide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Biotechne Cycloheximide Product Portfolio
- 4.7.5 Biotechne Recent Developments
- 4.8 Biosynth
- 4.8.1 Biosynth Company Information
- 4.8.2 Biosynth Business Overview
- 4.8.3 Biosynth Cycloheximide Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Biosynth Cycloheximide Product Portfolio
- 4.8.5 Biosynth Recent Developments
- 4.9 AK Scientific
- 4.9.1 AK Scientific Company Information
- 4.9.2 AK Scientific Business Overview
- 4.9.3 AK Scientific Cycloheximide Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 AK Scientific Cycloheximide Product Portfolio
- 4.9.5 AK Scientific Recent Developments
- 4.10 AHH Chemical
- 4.10.1 AHH Chemical Company Information
- 4.10.2 AHH Chemical Business Overview
- 4.10.3 AHH Chemical Cycloheximide Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 AHH Chemical Cycloheximide Product Portfolio
- 4.10.5 AHH Chemical Recent Developments
5 Global Cycloheximide Market Scenario by Region
- 5.1 Global Cycloheximide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cycloheximide Sales by Region: 2021-2032
- 5.2.1 Global Cycloheximide Sales by Region: 2021-2026
- 5.2.2 Global Cycloheximide Sales by Region: 2027-2032
- 5.3 Global Cycloheximide Revenue by Region: 2021-2032
- 5.3.1 Global Cycloheximide Revenue by Region: 2021-2026
- 5.3.2 Global Cycloheximide Revenue by Region: 2027-2032
- 5.4 North America Cycloheximide Market Facts & Figures by Country
- 5.4.1 North America Cycloheximide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cycloheximide Sales by Country (2021-2032)
- 5.4.3 North America Cycloheximide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cycloheximide Market Facts & Figures by Country
- 5.5.1 Europe Cycloheximide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cycloheximide Sales by Country (2021-2032)
- 5.5.3 Europe Cycloheximide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cycloheximide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cycloheximide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cycloheximide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cycloheximide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cycloheximide Market Facts & Figures by Country
- 5.7.1 South America Cycloheximide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cycloheximide Sales by Country (2021-2032)
- 5.7.3 South America Cycloheximide Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cycloheximide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cycloheximide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cycloheximide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cycloheximide Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cycloheximide Sales by Type (2021-2032)
- 6.1.1 Global Cycloheximide Sales by Type (2021-2032) & (g)
- 6.1.2 Global Cycloheximide Sales Market Share by Type (2021-2032)
- 6.2 Global Cycloheximide Revenue by Type (2021-2032)
- 6.2.1 Global Cycloheximide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cycloheximide Revenue Market Share by Type (2021-2032)
- 6.3 Global Cycloheximide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cycloheximide Sales by Application (2021-2032)
- 7.1.1 Global Cycloheximide Sales by Application (2021-2032) & (g)
- 7.1.2 Global Cycloheximide Sales Market Share by Application (2021-2032)
- 7.2 Global Cycloheximide Revenue by Application (2021-2032)
- 7.2.1 Global Cycloheximide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cycloheximide Revenue Market Share by Application (2021-2032)
- 7.3 Global Cycloheximide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cycloheximide Value Chain Analysis
- 8.1.1 Cycloheximide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cycloheximide Production Mode & Process
- 8.2 Cycloheximide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cycloheximide Distributors
- 8.2.3 Cycloheximide Customers
9 Global Cycloheximide Analyzing Market Dynamics
- 9.1 Cycloheximide Industry Trends
- 9.2 Cycloheximide Industry Drivers
- 9.3 Cycloheximide Industry Opportunities and Challenges
- 9.4 Cycloheximide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst